Ocumetics Technology Corp. (OTCFF)
| Market Cap | 52.30M +77.0% |
| Revenue (ttm) | n/a |
| Net Income | -5.94M |
| EPS | -0.05 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.4055 |
| Previous Close | 0.4055 |
| Day's Range | 0.4055 - 0.4055 |
| 52-Week Range | 0.2400 - 1.4000 |
| Beta | 0.32 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 25, 2026 |
About Ocumetics Technology
Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed its name to Ocumetics Technology Corp. in August 2021. The company was founded in 2012 and is headquartered in Calgary, Canada. [Read more]
News
Ocumetics Announces Significant Debt Conversion Strengthening Balance Sheet Ahead of Patient Study Milestones
Key Highlights $1.4 million of debenture principal converted to common shares of Ocumetics
Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens
Key Highlights Precision molds received for manufacturing of new optimized accommodating intraocular lenses
Ocumetics Announces Offering of Units
Calgary, Alberta – TheNewswire - April 29, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a priv...
Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life
Key Highlights Vision performance: Clinical outcomes exceed expectations, with all patients experiencing continuing vision improvements
Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change
Key Highlights No material change: There is no material change in the business affairs of Ocumetics.
Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting
Key Highlights Early First-in-Human clinical results have drawn the attention of industry leaders and several of the largest vision care technology companies in the world.
Ocumetics Technology Corp. Achieves Breakthrough in Next-Generation Accommodating Intraocular Lens Design
Key Highlights Breakthrough Accommodating Interocular Lens Design: The enhanced lens design introduces several novel concepts that are expected to improve substantially upon the consistency, durabil...
Ocumetics Announces Issuance of Stock Options
Calgary, Alberta – March 13, 2026 – TheNewswire - Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) (the “ Corporation ”) announces that it has issued 500,000 incentive stock options ...
Ocumetics Announces Scientific Advisory Committee to Support Advancing Clinical and Regulatory Strategy
Calgary, Alberta – TheNewswire - February 26, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technolog...
Ocumetics Announces Appointment of Raymond Marks to Board of Directors
Calgary, Alberta – TheNewswire - February 24, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technolog...
Ocumetics Announces Forbearance Agreement for $4 Million Secured Convertible Debentures and Provides LIFE Offering Update
Calgary, Alberta – February 10, 2026 – TheNewswire - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce that the Corporatio...
Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology
Key Highlights Positive First-in-Human Results: Three-month Group 1 data met or exceeded expectations for safety, lens delivery, and vision performance.
Ocumetics Announces Proposed Forbearance Agreement for $4 million Secured Convertible Debentures
Calgary, Alberta – January 30, 2026 – TheNewswire - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it is seeking approval from ...
Ocumetics Announces Transition of Chief Medical Officer Consulting Role
Calgary, Alberta – TheNewswire - January 9, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology,...
Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital
Calgary, AB – TheNewswire - January 2, 2026 – Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QB0) is pleased to announce that it has closed the fir...
Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital
Calgary, AB – TheNewswire - December 19, 2025 – Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QB0) announces that further to its previously announ...
Ocumetics Announces Optimized Lens Delivery System in Collaboration with Medicel
Calgary, Alberta – TheNewswire - December 9, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology...
Ocumetics Technology Announces $2.5 Million Brokered LIFE Offering Led by Centurion One Capital
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Calgary, AB – TheNewswire - November 25, 2025 – Ocumetics Technology Corp. (“ Ocumetics ” or the “ C...
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations
Calgary, Alberta – TheNewswire - November 5, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology...
Ocumetics to Present at the Centurion One Capital 3rd Annual Bahamas Summit
Calgary, Alberta – TheNewswire - October 24, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pl...